39:16

Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors

31:53

Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease

51:31

Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?

38:36

Atrial Fibrillation: New Solutions for an Old Problem

15:09

touchFOCUS Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches

1:29:22

Sepsis ve Septik Şok

30:43

Signs of Recurrence and How to Monitor: Beth Beadle, MD, Radiation Oncology

40:30

Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes